Nan Niu

4PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2025
Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pilot study.

Yu Zhang, Shuo Cao, Nan Niu

|Jul 02, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial.

Nan Niu, Jinqi Xue, Guanglei Chen

|May 05, 2023
KK-LC-1 as a therapeutic target to eliminate ALDH<sup>+</sup> stem cells in triple negative breast cancer.

Jiawen Bu, Yixiao Zhang, Sijin Wu

|Feb 06, 2023
Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study.

Nan Niu, Yinan Zhang, Yang Bai

Pageof 1

Frequent Collaborators

4 joint publications

Caigang Liu

2 joint publications

Yongliang Yang

1 joint publications

Xinbo Qiao

1 joint publications

Fang Qiu